Adverse events following ChAdOx1 nCoV-19 Vaccine (COVISHIELD) amongst health care workers: A prospective observational study

BACKGROUND: During ongoing COVID-19 pandemic, researchers worked enormously to develop effective vaccines against COVID-19 infection. Two Indian-made vaccines [Covishield (ChAdOx1 nCoV-19) and Covaxin] were granted Emergency Use Authorization. India launched its COVID-19 vaccination drive starting w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamal, Deep, Thakur, Vaidehi, Nath, Navneet, Malhotra, Tarun, Gupta, Aditya, Batlish, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313058/
https://www.ncbi.nlm.nih.gov/pubmed/34334895
http://dx.doi.org/10.1016/j.mjafi.2021.06.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313058/
https://www.ncbi.nlm.nih.gov/pubmed/34334895
http://dx.doi.org/10.1016/j.mjafi.2021.06.014

Ejemplares similares